About Triacetin
Triacetin (glyceryl triacetate) is hydrolyzed into glycerol and acetate in the body. Historically used as an excipient/plasticizer in pharmaceuticals and food (FDA GRAS since 1975). Recently repositioned as an active 'postbiotic' ingredient under the TriBiome brand (Compound Solutions). Animal studies show reduced weight gain and fat mass; ex vivo study showed increased SCFA production from IBS microbiomes; in vitro AMPK activation demonstrated. Zero human RCTs exist for any supplement use case. Marketing claims far outpace the science.
What Triacetin supports
- Preclinical evidence for short-chain fatty acid production in the gut
- Animal/in-vitro evidence for AMPK pathway activation
How much Triacetin to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
500–3000
mg
No human RCT has established a therapeutic dose. Animal studies use very high doses (30% of dietary energy). Commercial supplement doses are unvalidated.
Clinical evidence
Clinical evidence. Zero human clinical trials exist; only animal studies and in-vitro data